ESC 365 - Q&A and close

Open Access

Q&A and close

Session: Finerenone: a disease-modifying therapy for heart and kidney protection

Topic: Clinical

Sponsored by Bayer

Event: ESC Congress 2023

Congress Presentation

Add to my library

4 more presentations in this session

Welcome and introductions

Speaker: Doctor M. Kosiborod (Kansas City, US)

The emerging common framework of a chronic heart-kidney disorder

Speaker: Professor F. Zannad (Vandoeuvre-Les-Nancy, FR)

Improving kidney disease and cardiovascular outcomes with finerenone: from trials to clinical practice

Speaker: Professor G. Bakris (Chicago, US) Professor K. Marx-Schuett (Aachen, DE)

Investigating the potential effect of nonsteroidal MRA use in heart failure patient care

Speaker: Professor A. Voors (Groningen, NL) Doctor M. Kosiborod (Kansas City, US)

Access the full session

Finerenone: a disease-modifying therapy for heart and kidney protection

Speakers: Doctor M. Kosiborod, Professor F. Zannad, Professor G. Bakris, Professor K. Marx-Schuett, Professor A. Voors...

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources